Literature DB >> 15325130

Manipulation of PrPres production in scrapie-infected neuroblastoma cells.

Clive Bate1, Jan Langeveld, Alun Williams.   

Abstract

In the present study the accumulation of protease resistant prion protein (PrPres) in scrapie-infected neuroblastoma cells (ScN2a cells) was shown to be dependent on culture conditions. The highest levels of PrPres were found in slow growing cells. Further increases in PrPres accumulation were observed in ScN2a cells treated with retinoic acid, a compound that is associated with neuronal differentiation. The effects of retinoic acid were dose-dependent with a maximal effect at 200 ng/ml. A similar increase in PrPres was observed in another prion-infected cell line, scrapie-mouse brain (SMB) cells, treated with retinoic acid while retinoic acid increased the amount of PrPC in non-infected cells. Other drugs reported to cause neuronal differentiation, such as phorbol esters, did not increase the PrPres content of ScN2a cells. The survival of retinoic acid-treated ScN2a cells co-cultured with microglia was significantly reduced when compared to untreated ScN2a cells and an inverse correlation was demonstrated between the PrPres content of cells and their survival when co-cultured with microglia. The production of interleukin-6 by microglia cultured with retinoic acid-treated ScN2a cells was significantly higher than that of microglia cultured with untreated ScN2a cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15325130     DOI: 10.1016/j.jneumeth.2004.04.001

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  8 in total

1.  PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases.

Authors:  Mathéa Pietri; Caroline Dakowski; Samia Hannaoui; Aurélie Alleaume-Butaux; Julia Hernandez-Rapp; Audrey Ragagnin; Sophie Mouillet-Richard; Stéphane Haik; Yannick Bailly; Jean-Michel Peyrin; Jean-Marie Launay; Odile Kellermann; Benoit Schneider
Journal:  Nat Med       Date:  2013-08-18       Impact factor: 53.440

2.  RARB and STMN2 polymorphisms are not associated with sporadic Creutzfeldt-Jakob disease (CJD) in the Korean population.

Authors:  Byung-Hoon Jeong; Hae-Jung Kim; Kyung-Hee Lee; Richard I Carp; Yong-Sun Kim
Journal:  Mol Biol Rep       Date:  2014-01-12       Impact factor: 2.316

3.  The retinoic acid receptor beta (Rarb) region of Mmu14 is associated with prion disease incubation time in mouse.

Authors:  Julia Grizenkova; Shaheen Akhtar; John Collinge; Sarah E Lloyd
Journal:  PLoS One       Date:  2010-12-06       Impact factor: 3.240

4.  Anti-Prion Screening for Acridine, Dextran, and Tannic Acid using Real Time-Quaking Induced Conversion: A Comparison with PrPSc-Infected Cell Screening.

Authors:  Jae Wook Hyeon; Su Yeon Kim; Sol Moe Lee; Jeongmin Lee; Seong Soo A An; Myung Koo Lee; Yeong Seon Lee
Journal:  PLoS One       Date:  2017-01-17       Impact factor: 3.240

Review 5.  From Cell Culture to Organoids-Model Systems for Investigating Prion Strain Characteristics.

Authors:  Hailey Pineau; Valerie L Sim
Journal:  Biomolecules       Date:  2021-01-14

6.  Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study.

Authors:  Simon Mead; Mark Poulter; James Uphill; John Beck; Jerome Whitfield; Thomas E F Webb; Tracy Campbell; Gary Adamson; Pelagia Deriziotis; Sarah J Tabrizi; Holger Hummerich; Claudio Verzilli; Michael P Alpers; John C Whittaker; John Collinge
Journal:  Lancet Neurol       Date:  2009-01       Impact factor: 44.182

7.  Double-Edge Sword of Sustained ROCK Activation in Prion Diseases through Neuritogenesis Defects and Prion Accumulation.

Authors:  Aurélie Alleaume-Butaux; Simon Nicot; Mathéa Pietri; Anne Baudry; Caroline Dakowski; Philippe Tixador; Hector Ardila-Osorio; Anne-Marie Haeberlé; Yannick Bailly; Jean-Michel Peyrin; Jean-Marie Launay; Odile Kellermann; Benoit Schneider
Journal:  PLoS Pathog       Date:  2015-08-04       Impact factor: 6.823

8.  Production of seedable Amyloid-β peptides in model of prion diseases upon PrPSc-induced PDK1 overactivation.

Authors:  Juliette Ezpeleta; Vincent Baudouin; Zaira E Arellano-Anaya; François Boudet-Devaud; Mathéa Pietri; Anne Baudry; Anne-Marie Haeberlé; Yannick Bailly; Odile Kellermann; Jean-Marie Launay; Benoit Schneider
Journal:  Nat Commun       Date:  2019-08-01       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.